BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9664085)

  • 1. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
    Rajotte D; Arap W; Hagedorn M; Koivunen E; Pasqualini R; Ruoslahti E
    J Clin Invest; 1998 Jul; 102(2):430-7. PubMed ID: 9664085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ targeting in vivo using phage display peptide libraries.
    Pasqualini R; Ruoslahti E
    Nature; 1996 Mar; 380(6572):364-6. PubMed ID: 8598934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular targeting with phage peptide libraries.
    Pasqualini R
    Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synovium-specific homing peptides by in vivo phage display selection.
    Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
    Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the prostate for destruction through a vascular address.
    Arap W; Haedicke W; Bernasconi M; Kain R; Rajotte D; Krajewski S; Ellerby HM; Bredesen DE; Pasqualini R; Ruoslahti E
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1527-31. PubMed ID: 11830668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular adaptors for vascular-targeted adenoviral gene delivery.
    Trepel M; Grifman M; Weitzman MD; Pasqualini R
    Hum Gene Ther; 2000 Sep; 11(14):1971-81. PubMed ID: 11020797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.
    Yang Yu ; Zizheng Wang ; Tongxin Du
    J Biomol Screen; 2008 Dec; 13(10):968-74. PubMed ID: 18978306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular addresses of tumors: selection by in vivo phage display.
    Li XB; Schluesener HJ; Xu SQ
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer].
    Wang Y; Wu KC; Nie YZ; Han ZY; Han QL; Qiao TD; Fan DM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):469-72. PubMed ID: 15169660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening phage display libraries for organ-specific vascular immunotargeting in vivo.
    Valadon P; Garnett JD; Testa JE; Bauerle M; Oh P; Schnitzer JE
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):407-12. PubMed ID: 16384919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques to decipher molecular diversity by phage display.
    Christianson DR; Ozawa MG; Pasqualini R; Arap W
    Methods Mol Biol; 2007; 357():385-406. PubMed ID: 17172704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor vasculature with homing peptides from phage display.
    Ruoslahti E
    Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of homing peptides using the in vivo phage display technology.
    Rivinoja A; Laakkonen P
    Methods Mol Biol; 2011; 683():401-15. PubMed ID: 21053146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display.
    Rafii S; Avecilla ST; Jin DK
    Cancer Cell; 2003 Nov; 4(5):331-3. PubMed ID: 14667498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic diversity of the lung vasculature in experimental models of metastases.
    Oh Y; Mohiuddin I; Sun Y; Putnam JB; Hong WK; Arap W; Pasqualini R
    Chest; 2005 Dec; 128(6 Suppl):596S-600S. PubMed ID: 16373855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptor ligands with phage display peptide libraries.
    Koivunen E; Arap W; Rajotte D; Lahdenranta J; Pasqualini R
    J Nucl Med; 1999 May; 40(5):883-8. PubMed ID: 10319765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries.
    Clément G; Bisoffi M; Finger AN; Wetterwald A; Thalmann GN; Cecchini MG
    J Immunol Methods; 2003 May; 276(1-2):135-41. PubMed ID: 12738366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of the peptides specifically binding to hepatoma by using phage display in vivo].
    Du B; Yu J; Zhou ZL; Zhang P; Yu M; Qian M
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):645-7. PubMed ID: 16438882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.